Gaayou Numbing

Manufacturer
Jiangxi Hemei Pharmaceutical Co., Ltd
Effective date
2025-09-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:34:22

Label at a glance#

ProductGaayou Numbing
Active ingredientDIBUCAINE HYDROCHLORIDE
Label structure13 sections

Dosage and administration

Before applying the numbing cream,make sure to wash your hands thoroughly and put on disposable procedure gloves. Clean the area of the body receivina the procedure,Dry completely. Apply a generous amount of numbing cream to the cleaned area and rub it in thoroughly in a circlar motion for 30 to 60 seconds,Then. cover with plastic wrap. Leave the cream and wrap in place for 30 to 45 minutes,Wipe away the cream and...

Storage and handling

Store between 15-30℃(59-86F). Avoid freezing and excessive heat above 40 ℃(104°F).

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Dibucaine hydrochloride 0.5%

Purpose

OTC - PURPOSE SECTION

Local Anesthetic

Use

INDICATIONS & USAGE SECTION

For temporary relief of local discomfort, itching, pain, soreness, or burning associated with minor skin procedure.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

In children less than 2 year of age on open skin wounds Do not exceed the recommended daily dosage unless directed by a doctor

When Using

OTC - WHEN USING SECTION

Avoid contact with eyes, lf this happens, rinse thoroughly with water.

Stop Use

OTC - STOP USE SECTION

If symptoms persist for more than 7 days or subside but occur again within 3 days, stop use and consult a physician. Stop use and sek meditcal attention if signs of an alergy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help.

Ask Doctor

OTC - ASK DOCTOR SECTION

If symptoms persist for more than 7 days or subside but occur again within 3 days, stop use and consult a physician. Stop use and sek meditcal attention if signs of an alergy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

Before applying the numbing cream,make sure to wash your hands thoroughly and put on disposable procedure gloves.

Clean the area of the body receivina the procedure,Dry completely.

Apply a generous amount of numbing cream to the cleaned area and rub it in thoroughly in a circlar motion for 30 to 60 seconds,Then. cover with plastic wrap.

Leave the cream and wrap in place for 30 to 45 minutes,Wipe away the cream and thoroughly clean the area to prepare for the upcoming procedure.

Other information

STORAGE AND HANDLING SECTION

Store between 15-30℃(59-86F). Avoid freezing and excessive heat above 40 ℃(104°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Purifed Water,Thymol,tween,Carbomeralcohol,azone.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.50.5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84010-19284010-192-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a47bb70-eb28-a1ba-e063-6394a90a61123fe8f3b6-82e3-b16b-e063-6394a90a7c9f2026-02-07WarningsExact identifier
spl set id: 3fe8f3b6-82e3-b16b-e063-6394a90a7c9f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.